文献速递免疫规划传染病防控与疫情报告

爱尔兰2024年儿童麻疹抗体血清流行率横断面研究

Cross-sectional seroprevalence study of measles antibodies among children to identify gaps in population immunity, Ireland, 2024.
PubMed 文献 · Euro Surveill · 2026-01-01

该研究为2024年2月1日至6月19日在爱尔兰四个卫生区域医院实验室开展的儿童麻疹IgG抗体血清流行率横断面调查,采用便利抽样检测3-17岁儿童残留血清。结果显示总血清阳性率为90.3%(95%CI:89.2-91.4),3-9岁儿童保护接近充足,而10-17岁儿童保护不足(<95%),提示该免疫缺口未反映在疫苗覆盖率数据中。

要点

  • 3-5岁和6-9岁儿童麻疹IgG血清阳性率显著高于10-13岁和14-17岁儿童。
  • 10-17岁儿童血清阳性率低于95%,提示该年龄组免疫保护不足。
  • 血清流行率数据可揭示疫苗覆盖率数据未反映的免疫缺口。

核心结论

  • 3-9岁儿童对麻疹的保护接近充足,但10-17岁儿童保护不足(<95%),存在免疫缺口。
  • 该免疫缺口未反映在麻疹疫苗覆盖率数据中,凸显血清流行率数据对了解人群临床保护的价值。

研究设计与样本

  • 横断面血清流行率研究,于2024年2月1日至6月19日在爱尔兰四个卫生区域医院实验室进行便利抽样。
  • 检测3-17岁儿童匿名残留血清样本中的麻疹IgG抗体,使用商业化学发光免疫分析法。
  • 共检测2924份样本,其中2509份血清阳性、415份血清阴性。
  • 血清阳性率根据检测灵敏度和特异度进行调整,并按性别、年龄和地点计算。

主要发现

  • 总麻疹IgG血清阳性率为90.3%(95%CI:89.2-91.4),性别间无显著差异。
  • 3-5岁儿童血清阳性率为94.9%(95%CI:92.4-96.6),6-9岁为94.2%(95%CI:91.7-95.9)。
  • 10-13岁儿童血清阳性率为89.1%(95%CI:86.6-91.3),14-17岁为87.6%(95%CI:85.5-89.4)。
  • 3-5岁和6-9岁儿童血清阳性率显著高于10-13岁和14-17岁儿童。

临床怎么用

  • 应关注10-17岁儿童麻疹免疫保护不足,考虑加强免疫或补种策略。
  • 血清流行率数据可作为疫苗覆盖率数据的补充,用于评估人群免疫保护水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUNDGlobal resurgence of measles highlights the need for countries to identify and address immunity gaps. This is challenging given antibody waning and, in Ireland, the absence of robust national vaccine coverage data, population changes due to migration and outdated population-level seroprevalence data from the last national serosurvey (2003).AIMWe aimed to determine the seroprevalence of measles IgG in children aged 3-17 years in Ireland.METHODSConvenience sampling of anonymised residual serum samples from four hospital laboratories across four of six health regions was conducted between 1 February and 19 June 2024. Samples were tested for measles IgG antibodies using a commercial chemiluminescence immunoassay. Seropositivity was adjusted for test sensitivity and specificity and was calculated by sex, age and location.RESULTSIn total 2,509 of 2,924 samples were seropositive and 415 were seronegative indicating measles IgG seroprevalence of 90.3% (95% confidence interval (CI): 89.2-91.4), with no significant difference by sex. Children aged 3-5 years (94.9%; 95% CI: 92.4-96.6) and 6-9 years (94.2%; 95% CI: 91.7-95.9) had significantly higher seropositivity when compared with children aged 10-13 years (89.1%; 95% CI: 86.6-91.3) and 14-17 years (87.6%; 95% CI: 85.5-89.4).CONCLUSIONOur findings suggest close to adequate protection against measles among children 3-9 years but suboptimal (< 95%) protection among children aged 10-17 years. This immunity gap is not reflected in measles vaccine coverage data, highlighting the utility of seroprevalence data to enhance knowledge of clinical protection at population level and to inform vaccination strategies.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Brady M, Brouwer L, O' Brien K, et al. Cross-sectional seroprevalence study of measles antibodies among children to identify gaps in population immunity, Ireland, 2024. Euro Surveill. 2026. PMID: 41788028. doi:10.2807/1560-7917.ES.2026.31.9.2500313

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。